Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
June 11, 2015
Compliance with results reporting at ClinicalTrials.gov
Zachary P Hallinan, Kenneth A Getz, Barbara E Bierer
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
New Governance Mechanisms to Optimize Protocol Design
Kenneth A Getz, Jennifer Kim, Stella Stergiopoulos, et al.
Therapeutic Innovation & Regulatory Science
|
June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical Development
Abigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science
|
February 3, 2020
Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
Stella Stergiopoulos, Debra L Michaels, Barbara Lopez Kunz, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
An Overview and Analysis Regarding the Use of Adjudication Methods in EU and US Drug Approvals
Stephanie Krumholz-Bahner, Mimmo Garibbo, Kenneth A Getz, et al.
Therapeutic Innovation & Regulatory Science
|
July 20, 2021
Evaluating the Feasibility and Validity of a New Tool to Assess Organizational Preparedness and Capabilities to Support Patient Engagement in Drug Development
Debra L Michaels, Yaritza Peña, Barbara Lopez Kunz, et al.
Drug Safety
|
September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals
Stella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and Insulins
Stella Stergiopoulos, Carrie A Brown, Gustavo Grampp, et al.
Therapeutic Innovation & Regulatory Science
|
April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug Development
Joseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
American Journal of Therapeutics
|
September 23, 2008
Assessing the impact of protocol design changes on clinical trial performance
Kenneth A Getz, Julia Wenger, Rafael A Campo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
June 11, 2015
Compliance with results reporting at ClinicalTrials.gov
Zachary P Hallinan, Kenneth A Getz, Barbara E Bierer
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
New Governance Mechanisms to Optimize Protocol Design
Kenneth A Getz, Jennifer Kim, Stella Stergiopoulos, et al.
Therapeutic Innovation & Regulatory Science
|
June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical Development
Abigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science
|
February 3, 2020
Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
Stella Stergiopoulos, Debra L Michaels, Barbara Lopez Kunz, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
An Overview and Analysis Regarding the Use of Adjudication Methods in EU and US Drug Approvals
Stephanie Krumholz-Bahner, Mimmo Garibbo, Kenneth A Getz, et al.
Therapeutic Innovation & Regulatory Science
|
July 20, 2021
Evaluating the Feasibility and Validity of a New Tool to Assess Organizational Preparedness and Capabilities to Support Patient Engagement in Drug Development
Debra L Michaels, Yaritza Peña, Barbara Lopez Kunz, et al.
Drug Safety
|
September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals
Stella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and Insulins
Stella Stergiopoulos, Carrie A Brown, Gustavo Grampp, et al.
Therapeutic Innovation & Regulatory Science
|
April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug Development
Joseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
American Journal of Therapeutics
|
September 23, 2008
Assessing the impact of protocol design changes on clinical trial performance
Kenneth A Getz, Julia Wenger, Rafael A Campo, et al.
Page
of 4